Nortin Hadler, MD: lack of evidence for widespread statin use

Produced and interviewed by Steven Greer, MD

Nortin Hadler, MD, Professor of medicine and microbiology/immunology at The University of North Carolina School of Medicine, discusses the weakness in the body of literature to support the widespread usage of statins to lower cholesterol.

Nortin Hadler, MD: inappropriate use of epidemiology data

Nortin Hadler, MD, Professor of medicine and microbiology/immunology at The University of North Carolina School of Medicine, discusses the inappropriate use of broad epidemiology studies to draw conclusions that guide actual clinical therapy.

James Evans, MD, PhD: Genetic testing for breast cancer screening

With advances in genetic testing to determine high-risk mutations such as BRCA, can genetic tests available now help determine which women do not need routine mammography versus those who need early and aggressive screening? James Evans, MD, PhD, Editor-in-Chief of the journal “Genetics in Medicine” discusses the matter.

Nortin Hadler, MD: problems with combined endpoints

Nortin Hadler, MD, Professor of medicine and microbiology/immunology at The University of North Carolina School of Medicine, discusses the problems of using combined endpoints for clinical trials.

James Evans, MD: personalized medicine, Part 1

James Evans, MD, Professor of genetics and medicine at The University of North Carolina Medical Center, and Editor-in-Chief of the journal Genetics in Medicine, discusses the various clinical applications of genetic test to guide drug therapies.

James Evans, MD: personalized medicine, Part 2

James Evans, MD, Professor of genetics and medicine at the University of North Carolina, and Editor-in-Chief of the journal Genetics in medicine, discusses the various clinical applications of genetic test to guide drug therapies.

Nortin Hadler, MD: the misleading use of relative risk statistics

Norton Hadler, MD, discusses the statistical ploy of using relative risk numbers, such as “A 30% reduction in….” rather than the more modest, clinically insignificant, absolute values.